Increase in Out-of-Pocket Costs Could Increase Abandonment of HIV PrEP Meds

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Jan. 8, 2024 -- An increase in out-of-pocket costs for HIV preexposure prophylaxis (PrEP) medications could increase abandonment of PrEP, leading to an increase in HIV diagnoses, according to a study published in the January issue of Health Affairs.

Lorraine T. Dean, Sc.D., from Johns Hopkins University in Baltimore, and colleagues estimated the risk-adjusted percentages of patients who abandoned their initial PrEP prescription across six out-of-pocket spending categories in a sample of 58,529 people with a new insurer-approved PrEP prescription. The percentage of patients who would abandon PrEP under hypothetical changes to out-of-pocket spending ranging from $0 to $500 was then simulated.

The researchers found that abandonment rates increased from 5.5 percent at $0 to 42.6 percent at >$500; there was a doubling in abandonment observed with a small increase from $0 to $10. Conversely, a decrease in abandonment rates was seen from 48.0 percent at >$500 to 7.3 percent at $0. Patients who abandoned versus filled PrEP prescriptions had a two to three times higher rate of HIV diagnoses.

"Our findings suggest that out-of-pocket cost increases for PrEP could upend the progress that has been made towards ending the HIV/AIDS epidemic in the United States," senior author Jalpa Doshi, Ph.D., from the University of Pennsylvania in Philadelphia, said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-09 22:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords